Product
Hydroxychloroquine
Aliases
HCQ, Hydroxychloroquine (HCQ) (Cohort B), Hydroxychloroquine, Metformin, Sirolimus, Nelfinavir, Hydroxychloroquine, Metformin, Sirolimus, Nelfinavir, Dasatinib (6 other aliases)
Name
Hydroxychloroquine Sulfate
INN Name
Hydroxychloroquine sulfate
FDA Approved
Yes
79 clinical trials
29 organizations
120 indications
3 documents
Indication
Pancreatic CancerIndication
TumorIndication
SolidIndication
Gastrointestinal CancerIndication
COVID-19Indication
HealthyIndication
CholangiocarcinomaIndication
perihilarIndication
extrahepaticIndication
IntrahepaticIndication
Rheumatoid ArthritisIndication
MiscarriageIndication
chronic kidney diseaseIndication
Cardiovascular DiseaseIndication
InflammationIndication
AtherosclerosisIndication
Aortic StiffnessIndication
IgA NephropathyIndication
Hepatocellular CarcinomaIndication
Healthy ParticipantsIndication
Systemic Lupus ErythematosusIndication
Prostate Cancer RecurrentIndication
Solid TumorIndication
AdultIndication
MelanomaIndication
Pancreatic AdenocarcinomaIndication
Colorectal CancerIndication
Interstitial Lung DiseaseIndication
Surfactant DysfunctionIndication
Ulcerative ColitisIndication
Coronavirus InfectionIndication
SARS-CoV-2Indication
Retinitis PigmentosaIndication
Breast CancerIndication
Stage II Breast CancerIndication
Stage IIB Breast CancerIndication
Breast Cancer, Stage IVIndication
Breast Cancer AJCC Stage IAIndication
Stage IIA Breast CancerIndication
Stage IIIA Breast CancerIndication
Stage IIIB Breast CancerIndication
Stage IV Breast Cancer AJCC v8Indication
Recurrent Pregnancy LossIndication
AbortionIndication
PreeclampsiaIndication
Colorectal NeoplasmsIndication
Type 2 Diabetes MellitusIndication
Pancreatic Cancer, Stage IIIndication
Stage IIB Pancreatic CancerIndication
Stage III Pancreatic CancerIndication
Unresectable Pancreatic CarcinomaIndication
OsteosarcomaIndication
Inflammatory CardiomyopathyIndication
MyocarditisIndication
SarcoidosisIndication
PulmonaryIndication
Gastrointestinal NeoplasmsIndication
Prostate CancerIndication
Graves OphthalmopathyIndication
Gynecologic CancerIndication
NeuropathyIndication
Peripheral neuropathyIndication
ArthritisIndication
Joint painIndication
Advanced CancerIndication
Breast Cancer Stage IIBIndication
Stage IV Cutaneous MelanomaIndication
Stage IIIC Cutaneous Melanoma AJCC v8Indication
Cutaneous MelanomaIndication
melanomaIndication
KRAS Mutation-Related TumorsIndication
CirrhosisIndication
Muscle CrampsIndication
SARSIndication
Bile Duct CancerIndication
Biliary Tract NeoplasmsIndication
pre-eclampsiaIndication
Gastroesophageal Junction AdenocarcinomaIndication
Lung AdenocarcinomaIndication
Malignant NeoplasmIndication
Ovarian CancerIndication
Pancreatic CarcinomaIndication
Bladder CancerIndication
Metastatic Biliary Tract CarcinomaIndication
Colorectal cancerIndication
Metastatic Urothelial CarcinomaIndication
Biliary Tract CancerIndication
Urothelial CarcinomaIndication
Stage III Lung Cancer AJCC v8Indication
Stage III Ovarian Cancer AJCC v8Indication
Colorectal Cancer stage IV AJCC v8Indication
Stage IV Lung CancerIndication
Stage IV Ovarian CancerIndication
Infectious DiseaseIndication
Malignant Solid TumourIndication
Stage III Cutaneous Melanoma AJCC v7Indication
Stage III Prostate Cancer AJCC v7Indication
Renal Cell Cancer, Stage III (AJCC v7)Indication
Stage IIIA Cutaneous Melanoma AJCC v7Indication
Prostate Cancer, Stage IV AJCC v7Indication
Renal Cell CancerIndication
Porphyria Cutanea TardaIndication
Type 1 Diabetes MellitusIndication
Connective Tissue DiseasesIndication
Pregnancy RelatedIndication
Community-acquired PneumoniaIndication
InfluenzaIndication
NSCLCIndication
Sudden Sensorineural Hearing LossIndication
Sjögren's syndromeClinical trial
A Multicenter, Open-label, ExploRatory Platform Trial to EValuate ImmunOtherapy Combinations With Chemotherapy for the Treatment of Patients With PreviousLy UnTreated MetastatIc Pancreatic AdenOcarciNoma (REVOLUTION)Status: Active (not recruiting), Estimated PCD: 2024-10-31
Clinical trial
A Phase 2 Basket Trial of Ulixertinib (BVD-523) in Combination With Hydroxychloroquine in Patients With Advanced GI Malignancies Harboring Mitogen-activated Protein Kinase (MAPK) Pathway Mutations (BVD-523-HCQ)Status: Recruiting, Estimated PCD: 2024-12-06
Clinical trial
Open Label, Multicentric, Non Randomized, Exploratory Clinical Trial to Assess the Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Mild Acute Respiratory Syndrome (COVID-19) Caused by SARS-CoV-2 VirusStatus: , Estimated PCD: 2020-06-30
Clinical trial
A Phase 1, Open-Label Study to Investigate Drug-Drug Interaction (DDI) Potential of Nipocalimab With Coadministration of Etanercept or Hydroxychloroquine in Healthy ParticipantsStatus: Completed, Estimated PCD: 2022-05-27
Clinical trial
A Phase I/IIA Study of ABC294640 Alone and in Combination With Hydroxychloroquine Sulfate in the Treatment of Patients With Advanced, Unresectable Intra-hepatic, Perihilar and Extra-Hepatic CholangiocarcinomaStatus: Completed, Estimated PCD: 2022-06-21
Clinical trial
Open, Multicentric, Non Randomized, Exploratory Clinical Trial to Assess the Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Acute Respiratory Syndrome (COVID-19) Caused by SARS-CoV-2 VirusStatus: , Estimated PCD: 2020-05-31
Clinical trial
A Phase II, Blinded, Randomised, Placebo Controlled Clinical Trial to Determine the Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid ArthritisStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
Hydroxychloroquine for Improvement of Pregnancy Outcome in Unexplained Recurrent MiscarriageStatus: Completed, Estimated PCD: 2023-03-10
Clinical trial
Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine (HCQ) for BRAF V600E-mutant or Trametinib and HCQ for BRAF Fusion/Duplication Positive or NF1-associated Recurrent or Progressive Gliomas in Children and Young AdultsStatus: Recruiting, Estimated PCD: 2026-08-30
Clinical trial
Hydroxychloroquine for the Management of CVD in CKDStatus: Completed, Estimated PCD: 2024-01-31
Clinical trial
Hydroxychloroquine and Cognitive Function After SurgeryStatus: Active (not recruiting), Estimated PCD: 2023-05-22
Clinical trial
Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA)Nephropathy Course QUIgAN StudyStatus: Not yet recruiting, Estimated PCD: 2027-12-31
Clinical trial
Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid ArthritisStatus: Terminated, Estimated PCD: 2022-11-01
Clinical trial
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma Through Image-guided Locoregional TherapyStatus: Not yet recruiting, Estimated PCD: 2027-08-31
Clinical trial
Study of Anti-Malarials in Incomplete Lupus ErythematosusStatus: Active (not recruiting), Estimated PCD: 2024-09-01
Clinical trial
Combination of Autophagy Selective Therapeutics (COAST) in Advanced Solid Tumors or Relapsed Prostate Cancer, A Phase I/II TrialStatus: Recruiting, Estimated PCD: 2024-10-15
Clinical trial
LIMIT Melanoma: (Lysosomal Inhibition + Melanoma ImmunoTherapy) A Phase 1/2 Open Label Trial of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Patients With Advanced MelanomaStatus: Recruiting, Estimated PCD: 2025-10-30
Clinical trial
Proteomics Combined With Metabolomics Studies on the Efficacy of Telitacicept in Chinese Patients of Systemic Lupus ErythematosusStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Phase I/II Study of Neoadjuvant mFOLFIRINOX in Combination With Peri-operative Oral Hydroxychloroquine (FHQ) in Subjects With Resectable Adenocarcinoma of the Pancreas.Status: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Phase IIa Study of Quintuple Therapy to Treat COVID-19 InfectionStatus: Completed, Estimated PCD: 2024-02-27
Clinical trial
Modulation of Autophagy: A Clinical Study of Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Refractory Metastatic Colorectal Cancer (mCRC) Patients (CTMS# 14-2015)Status: Completed, Estimated PCD: 2018-03-07
Clinical trial
Safety and Efficacy of Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes: a Randomized Controlled StudyStatus: Not yet recruiting, Estimated PCD: 2026-04-01
Clinical trial
Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative ColitisStatus: Active (not recruiting), Estimated PCD: 2025-12-01
Clinical trial
Oral Hydroxychloroquine for Retinitis Pigmentosa Caused by P23H-RHO (Substitution of Proline to Histidine at Codon 23 of the Rhodopsin Protein)Status: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
A Phase II Study of 5-FU, Irinotecan, Bevacizumab and Hydroxychloroquine in Drug-Tolerant Persister (DTP)-Selected Patients With Metastatic Colorectal CancerStatus: Recruiting, Estimated PCD: 2026-04-24
Clinical trial
A Phase III, Randomized, Double-Blind Placebo-Controlled, Non-Inferiority, Multi-Center Study of the Effects of Stopping Hydroxychloroquine in Elderly Lupus DiseaseStatus: Not yet recruiting, Estimated PCD: 2027-06-30
Clinical trial
Phase I/II Safety and Efficacy Study of Autophagy Inhibition With Hydroxychloroquine to Augment the Antiproliferative and Biological Effects of Pre-Operative Palbociclib Plus Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast CancerStatus: Completed, Estimated PCD: 2024-04-17
Clinical trial
Prévention Des Fausses Couches Spontanées Répétées Par Hydroxychloroquine. Essai thérapeutique Multicentrique, randomisé, en Double Insu, Contre PlaceboStatus: Active (not recruiting), Estimated PCD: 2025-11-01
Clinical trial
The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia: a Multicenter, Open-label, Single Arm Trial, Investigator Initiated StudyStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Hydroxychloroquine is an Immunomodulator for Improvement of Pregnancy Outcomes in PreeclampsiaStatus: Completed, Estimated PCD: 2023-07-30
Clinical trial
Phase 1B Study of Hepatic Chemoembolization Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Adenocarcinoma Of The Colon And RectumStatus: Terminated, Estimated PCD: 2024-04-25
Clinical trial
Phase II Trial of Paricalcitol and Hydroxychloroquine (PH) Combination With Gemcitabine and Nab-Paclitaxel in Advanced or Metastatic Pancreatic CancerStatus: Active (not recruiting), Estimated PCD: 2024-08-14
Clinical trial
THREAD: A Phase I Trial of Trametinib and Hydroxychloroquine in Patients With Advanced Pancreatic CancerStatus: Recruiting, Estimated PCD: 2025-01-18
Clinical trial
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseStatus: Recruiting, Estimated PCD: 2026-03-01
Clinical trial
A Phase 1/2 Study of Gemcitabine and Docetaxel in Combination With Hydroxychloroquine (Autophagy Inhibitor) in Patients With Recurrent OsteosarcomaStatus: Active (not recruiting), Estimated PCD: 2024-09-13
Clinical trial
The Efficacy and Mechanism of Hydroxychloroquine in Patients With Inflammatory Cardiomyopathy After MyocarditisStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis: Multicenter, Prospective, Placebo-controlled, Randomized TrialStatus: Not yet recruiting, Estimated PCD: 2028-04-01
Clinical trial
A Phase I Trial of Ulixertinib (BVD-523) and Hydroxychloroquine in Patients With Advanced MAPK-Mutated Gastrointestinal AdenocarcinomasStatus: Completed, Estimated PCD: 2022-06-10
Clinical trial
A Phase II Pilot Trial of ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer Patients ("ABBY")Status: Recruiting, Estimated PCD: 2027-12-01
Clinical trial
A Phase I/II Study of Hydroxychloroquine and Itraconazole as Therapy for Men With Androgen Normalised Prostate CancerStatus: Completed, Estimated PCD: 2023-08-30
Clinical trial
A Randomized Controlled Trial on the Effect of Hydroxychloroquine in Mild Graves' OrbitopathyStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Binimetinib Plus Hydroxychloroquine in KRAS Mutant Metastatic Pancreatic CancerStatus: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
Phase 2, Single Center, Single Arm Study to Evaluate the Decrease in CIPN With the Addition of Hydroxychloroquine to Chemotherapy in Patients With Early Stage (1-3) Breast Cancer and Gynecological Cancers Treated With Curative IntentStatus: Withdrawn, Estimated PCD: 2025-02-01
Clinical trial
Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients With Moderate or Severe COVID-19 InfectionStatus: Terminated, Estimated PCD: 2020-08-28
Clinical trial
Autophagic Modulation With Anti-angiogenic Therapy in Patients With Advanced Malignancies: A Phase I Trial of Sunitinib and HydroxychloroquineStatus: Completed, Estimated PCD: 2023-07-18
Clinical trial
A Study to Evaluate the Efficacy and Safety Hydroxychloroquine in Immune Related Arthritis or ArthralgiasStatus: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
Open-label, Randomized Controlled Trial of Hydroxychloroquine, Hydroxychloroquine Plus Azithromycin, Chloroquine Alone, Chloroquine Plus Azithromycin in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) InfectionStatus: Terminated, Estimated PCD: 2021-04-01
Clinical trial
Phase II Trial of ERK Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic CancerStatus: Completed, Estimated PCD: 2023-08-09
Clinical trial
Open, Controlled, Multicenter Phase I/II Clinical Study of Hydroxychloroquine in Combination With Antibody-drug Conjugate Versus Antibody-drug Conjugate for Advanced Breast Cancer.Status: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
Phase 1/2 Open-label Study of Combination Therapy With the MEK Inhibitor, Cobimetinib, Immune Checkpoint Blockade, Atezolizumab, and the AUTOphagy Inhibitor, Hydroxychloroquine in KRAS-mutated Advanced MalignanciesStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
A Phase II Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin+ Hydroxychlororoquine as Preoperative Treatment in Patients With Untreated Resectable, Borderline Resectable and Locally Advanced Adenocarcinoma of the PancreasStatus: Active (not recruiting), Estimated PCD: 2023-05-23
Clinical trial
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast CancerStatus: Active (not recruiting), Estimated PCD: 2022-05-17
Clinical trial
PaTcH Trial: A Phase 2 Study to Explore Primary and Emerging Resistance Mechanisms in Patients With Metastatic Refractory Pancreatic Cancer Treated With Trametinib and HydroxychloroquineStatus: Recruiting, Estimated PCD: 2024-07-15
Clinical trial
Modulation of Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular CancerStatus: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
The BAMM2 (BRAF, Autophagy, MEK Inhibition in Melanoma) Study: A Randomized Double Blind Phase II Study of Dabrafenib and Trametinib With or Without Hydroxychloroquine in Advanced BRAF V600E/K MelanomaStatus: Active (not recruiting), Estimated PCD: 2025-11-30
Clinical trial
The LIMIT KRAS Mutant NSCLC Trial: Lysosome Inhibition to Enhance MAPK Inhibition Targeting KRAS Mutant NSCLC: A Phase 2 Open Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung CancerStatus: Active (not recruiting), Estimated PCD: 2022-08-21
Clinical trial
A Pilot Study of Hydroxychloroquine for the Treatment of Muscle Cramps in Patients With CirrhosisStatus: Completed, Estimated PCD: 2015-04-01
Clinical trial
Randomised Evaluation of COVID-19 TherapyStatus: Recruiting, Estimated PCD: 2026-06-30
Clinical trial
Phase II Study of Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).Status: Terminated, Estimated PCD: 2022-05-11
Clinical trial
NEw Clinical Endpoints in Patients With Primary Sjögren's Syndrome (pSS): an Interventional Trial Based on stratifYing PatientsStatus: Recruiting, Estimated PCD: 2024-02-01
Clinical trial
Hydroxychloroquine Treatment During Pregnancy is Associated With Lower Risk of Preeclampsia in Patients With Recurrent Spontaneous Abortion of Unknown AetiologyStatus: Not yet recruiting, Estimated PCD: 2024-07-01
Clinical trial
Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic: A Multicentre, Double-Blinded Randomized Controlled TrialStatus: Completed, Estimated PCD: 2020-06-25
Clinical trial
High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19Status: Completed, Estimated PCD: 2020-06-10
Clinical trial
Phase II Open-Label Multi-Cohort Study Evaluating CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Patients With Advanced Chemorefractory Colorectal, Pancreatic, or Other Solid CancersStatus: Recruiting, Estimated PCD: 2028-01-04
Clinical trial
Hydroxychloroquine for Outpatients With Confirmed COVID-19Status: Completed, Estimated PCD: 2021-10-30
Clinical trial
Inhibition of Autophagy in Solid Tumors: A Phase I Pharmacokinetic and Pharmacodynamic Study of Hydroxychloroquine in Combination With the HDAC Inhibitor Vorinostat for the Treatment of Patients With Advanced Solid Tumors With an Expansion Study in Advanced Renal and Colorectal CancerStatus: Completed, Estimated PCD: 2017-12-05
Clinical trial
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers : A Randomized Double-blind Placebo-controlled Clinical TrialStatus: Terminated, Estimated PCD: 2020-05-13
Clinical trial
Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19Status: Terminated, Estimated PCD: 2020-10-14
Clinical trial
A Phase I Trial of MK-2206 and Hydroxychloroquine in Solid Tumors, Melanoma, Renal and Prostate Cancer to Examine the Role of Autophagy in TumorigenesisStatus: Active (not recruiting), Estimated PCD: 2020-02-14
Clinical trial
A Prospective Comparison of Low Dose Hydroxychloroquine and Phlebotomy in the Treatment of Porphyria Cutanea Tarda. IRB 02-435Status: Completed, Estimated PCD: 2021-07-06
Clinical trial
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)Status: Terminated, Estimated PCD: 2022-10-27
Clinical trial
A Multi-center, Prospective, Open-label, Randomized Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome PatientsStatus: Active (not recruiting), Estimated PCD: 2024-08-22
Clinical trial
The Clinical Features and Pregnancy Outcomes of Patients With Connective Tissue Disease :a Prospective Cohort StudyStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaStatus: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
Finding Treatments for COVID-19: A Phase 2 Multi-centre Adaptive Platform Trial to Assess Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)Status: Recruiting, Estimated PCD: 2027-01-01
Clinical trial
Efficacy and Safety of Hydroxychloroquine in the Treatment of Sudden Sensorineural Hearing LossStatus: Not yet recruiting, Estimated PCD: 2026-05-31
Clinical trial
The Efficacy and Safety of Hydroxychloroquine Plus Prednisone in Antinuclear Antibody-positive Patients With Primary Immune Thrombocytopenia-- The Multicenter, Randomized, Open-lable Clinical TrialStatus: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
The Efficacy and Safety of Hydroxychloroquine Plus Dexamethasone in Antinuclear Antibody-positive Patients With Primary Immune Thrombocytopenia-- The Multicenter, Randomized, Open-labled Clinical TrialStatus: Recruiting, Estimated PCD: 2026-01-01
Organization
A-S Medication SolutionsOrganization
Major PharmaceuticalsOrganization
Quallent Pharmaceuticals Health LLCOrganization
RedPharm Drug, Inc.Document
DailyMed Label: PlaquenilOrganization
Teva Pharmaceuticals USA, Inc.Organization
Amneal Pharmaceuticals NY LLCOrganization
Cardinal Health 107, LLCOrganization
NCS HealthCare of KY, LLC dba Vangard LabsOrganization
Sun Pharmaceutical Industries, Inc.Organization
Accord Healthcare, Inc.,Organization
bryant ranch prepackOrganization
Zydus Lifesciences LimitedOrganization
Zydus Pharmaceuticals USA Inc.Organization
American Health PackagingOrganization
Aphena Pharma Solutions - Tennessee, LLCOrganization
Preferred Pharmaceuticals, Inc.Organization
NuCare Pharmaceuticals,Inc.Organization
Laurus Labs LimitedOrganization
McKesson Corporation dba SKY PackagingOrganization
Rising Pharma Holdings, Inc.Organization
Asclemed USA, Inc.Document
DailyMed Label: SOVUNAOrganization
ANI Pharmaceuticals, Inc.Organization
Ipca Laboratories LimitedOrganization
Northstar Rx LLC.Organization
AvPAKOrganization
Chartwell RX, LLCOrganization
Dr. Reddy's Laboratories Inc.Organization
Aphena Pharma Solutions - Tennessee, LLC Organization
Concordia Pharmaceuticals Inc.